baber/WOPTO huggingface dataset:
Patent JP-H0454485-B2 (JP)
IPC: C08L89/00
Filed: 1985-03-08
Abstract: PCT No. PCT/EP85/00089 Sec. 371 Date Oct. 28, 1985 Sec. 102(e) Date Oct. 28, 1985 PCT Filed Mar. 8, 1985 PCT Pub. No. WO85/04111 PCT Pub. Date Sep. 26, 1985.A structure usable as an ultrafiltration membrane has membranes (20) with continuous pores which are linked to or into an appropriately porous carrier (21). Each of these membranes (20) consist of protein molecules or protein containing molecules arranged according to a two-dimensional crystal lattice, between which continuous pores of equal size and form remain free, and they are advantageously formed from molecules, which were particularly separated from cell-membranes of procaryons, by means of a recrystallization process designated as self-organization, and which are preferably deposited on or into the carrier (21) and are cross-linked with the carrier (21) intra- or intermolecularly, respectively, through foreign molecules. The structure is suitable, furthermore, for use as a separating organ for a gas separation or for an ion exchange process, as well as for use as a carrier structure for other semi-permeable membranes, such as hyperfiltration membranes. Moreover, with membranes in vesicle form it can serve as a chromatography column and, in the form of film, as envelope material for the most varied substances.
Patent JP-3010310-B2 (JP)
IPC: A61P35/00
Filed: 1990-03-20
Granted: 2000-02-21
Abstract: The use of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid or EPA, preferably substantially free of any other polyunsaturated fatty acids, is disclosed for making up medical preparations or compositions for the treatment of cachexia and/or malignant tumours in mammals and for inhibiting lipolytic activity of biologically active lipolytic agents present in body fluids and the activity of the enzyme guanidinobenzoatase, as well as for reducing abnormal cAMP levels in cells of adipose tissue in mammals, produced by lipolytic or fat mobilising substances.
Patent JP-3606325-B2 (JP)
IPC: A61K6/896
Filed: 1992-10-07
Granted: 2005-01-05
Abstract: The invention relates to a self-curing, photochemically or thermally curable resinous dental composition based on polymerisable polysiloxanes, to a process for its preparation and to its use for the preparation of pasty, self-curing, photochemically or thermally curable dental materials. Said composition is obtainable by hydrolytic condensation of one or more hydrolytically condensable silicon compounds, 1 to 100 mol %, based on monomeric compounds, of silanes of the general formula: Yn-SiXmR4-(n+m) and/or {XnRkSi[R2(A)l]4-(n+k)}xB being selected. The radicals A, X, Y, R2, R' and R are identical or different and have the following meaning: A=O, S, PR', POR', NHC(O)O or NHC(O)ONR', B=a straight-chain or branched organic radical which is derived from a compound B' having at least one (for l=1 and A=NHC(O)O or NHC(O)NR') or at least two C=C double bonds and 5 to 50 carbon atoms, R=alkyl, alkenyl, aryl, alkylaryl or arylalkyl, R'=H, alkyl or aryl, R2=alkylene, arylene or alkylenearylene, X=H, halogen, hydroxyl, alkoxy, acyloxy, alkylcarbonyl, alkoxycarbonyl or NR'2, Y=a substituent which contains a substituted or unsubstituted 1,4,6-trioxaspiro[4.4]nonane radical, n=1, 2 or 3, m=1, 2 or 3, where n+m</=4, k=0, 1 or 2, l=0 or 1, x=an integer whose value is stated in the description.
Patent JP-3625844-B2 (JP)
IPC: B01D24/28
Filed: 1997-08-11
Granted: 2005-03-02
Abstract: PCT No. PCT/DE97/01760 Sec. 371 Date Jul. 23, 1999 Sec. 102(e) Date Jul. 23, 1999 PCT Filed Aug. 11, 1997 PCT Pub. No. WO98/06473 PCT Pub. Date Feb. 19, 1998A continuous filter device for liquids has a filter chamber that receives a granular bulk material forming a filter bed. The filter chamber has rectangular inner-walls with a liquid-permeable inlet side and a liquid-permeable outlet side positioned opposite the inlet side. A liquid-impermeable outer wall is positioned at the inlet side and forms together with the inlet side an inlet chamber. The inlet side has openings allowing flow of a liquid to be filtered from the inlet chamber into the filter chamber. A liquid-impermeable outer mantle is positioned at the outlet side and forms together with the outlet side a filtrate collection chamber. The outlet side has openings allowing filtrate flow from the filter chamber into the filtrate collection chamber. A cone-shaped removal chamber is connected to a lower end of the filter chamber. A flow discharge chamber is connected to an upper end of the filter chamber. A bulk material separating apparatus is positioned in the flow discharge chamber for separating dirt particles from the bulk material. A lifting system has a removal tube with a lower suction end projecting into a bottom portion of the removal chamber and an upper end extending into the bulk material separating apparatus. Flow discharge devices are connected to the bulk material separating apparatus. The bulk material is removed by the removal tube from the removal chamber and guided into the bulk material separating apparatus from where it is flow discharged by the flow discharge devices onto the filter bed to form a bulk material heap that is non-uniform and arranged close to the outlet side.
Patent JP-3253633-B2 (JP)
IPC: A61P31/04
Filed: 1996-10-23
Granted: 2002-02-04
Abstract: Compositions and methods for using CTLA-8 to treat an abnormal physiological condition in an individual. The methods comprise administering a therapeutically effective amount of CTLA-8 alone, or in combination with other therapeutic reagents; or a CTLA-8 antagonist.
Patent JP-3839846-B2 (JP)
IPC: B01J8/06
Filed: 1995-09-22
Granted: 2006-11-01
Abstract: A vertical catalytic reactor for steam reforming a reactor fuel into a product gas, the catalytic reactor containing a catalyst forming a catalyst bed. If the catalytic reactor material has a thermal coefficient of expansion greater than the catalyst, then the catalytic reactor experiences problems due to thermal cycling. During the start-up of the catalytic reactor, the temperature increase causes the catalytic reactor to expand more than the catalyst, thus, the catalyst slumps within the catalytic reactor. During the shut-down of the catalytic reactor, the temperature decrease causes the catalytic reactor to contract and crush the slumped catalyst. The catalytic reactor incorporates a design (100) for reducing catalyst slumping and crushing.
Patent JP-3432225-B2 (JP)
IPC: B29C39/10
Filed: 1993-05-18
Granted: 2003-08-04
Abstract: PCT No. PCT/BE93/00026 Sec. 371 Date Jan. 19, 1995 Sec. 102(e) Date Jan. 19, 1995 PCT Filed May 19, 1993 PCT Pub. No. WO93/23237 PCT Pub. Date Nov. 25, 1993In the method according to the invention, a layer of polyurethane elastomer for obtaining a polyurethane skin (5) is produced, in a first step, against a mould surface (1). In a second step, a reaction mixture for obtaining a polyurethane foam layer (6) is applied against this polyurethane skin (5). In a third step, a suitable polyurethane or polyisocyanurate reaction mixture for obtaining a rigid synthetic carrier (8) is applied against the polyurethane foam layer (6). In this way, a synthetic trim part is obtained which is easier to recycle. This method can moreover also be performed easier.
Patent JP-4224621-B2 (JP)
IPC: B01D69/14
Filed: 1998-01-14
Granted: 2009-02-18
Abstract: A module for extracorporeal purification of a biological fluid includes at least one support or wall defining a compartment which is delimited by an ionic functionalized support or wall, the surface of which is bonded by ionic bonds to a first molecule or macromolecule which exhibits free amine groups to which are covalently bonded a second molecule or macromolecule which exhibits free carboxylic groups which can directly or indirectly form amide, ester or thioester bonds. The invention also includes methods of producing such module.
Patent ES-2277765-B2 (ES)
Title: Metodo para control de suspension neumatica de vehiculos industriales y dispositivo correspondiente.
Inventor: MORENO IBANEZ ALBERTO
IPC: B60G17/052
Filed: 2005-11-02
Granted: 2008-04-16
Abstract: Método para control de suspensión neumática de vehículos industriales y dispositivo correspondiente. Consiste en un método y un dispositivo para mantener constante la altura de la plataforma del vehículo en circulación, ajuste manual de la altura de la plataforma en parado, para nivelación con el muelle de carga, limitación de su altura máxima, retorno automático a función de altura de circulación cuando el vehículo inicia la marcha, que combina las dichas funciones con la de mantenimiento constante a nivel con el muelle de carga, durante la carga o descarga, de cualquier valor de altura previamente seleccionado manualmente, independientemente del estado de carga del vehículo; mediante dos módulos, uno de nivelación (7) y uno de mando (9), conectados entre sí y el primero de ellos también con los sistemas del vehículo, utiliza una tecnología de tipo mecánico-neumática. De aplicación en la fabricación de dispositivos de control de suspensión neumática de vehículos industriales.
Patent ES-2293813-B2 (ES)
Title: Una aleacion de al-zn-mg-cu.
Inventor: KEIDEL CHRISTIAN
IPC: C22C21/10
Filed: 2004-04-09
Granted: 2011-06-29
Abstract: Una aleación de
Al-Zn-Mg-Cu. 
     La presente invención se refiere a un producto
de  aleación de aluminio que consiste, esencialmente, en % en  peso,
en aproximadamente 6,5 a 9,5 de zinc (Zn),  aproximadamente 1,2 a
2,2% de magnesio (Mg), aproximadamente 1,0 a 1,9% de cobre (Cu),
preferiblemente (0,9 Mg -   0,6) \leq Cu \leq (0,9 Mg -
0,05), aproximadamente 0 a 0,5% de zirconio (Zr), aproximadamente 0
a 0,7% de escandio (Sc),  aproximadamente 0 a 0,4% de cromo (Cr),
aproximadamente 0 a  0,3% de hafnio (Hf), aproximadamente 0 a 0,4%
de titanio  (Ti), aproximadamente 0 a 0,8% de manganeso (Mn), siendo
el  resto aluminio (Al) y otros elementos incidentales. La 
invención se refiere también a un método para manufacturar  una
aleación de este tipo.
Patent ES-2334868-B2 (ES)
Title: Fotometro lineal robusto de ganancia variable.
Inventor: HERNANDEZ PERDOMO WILMAR
IPC: G01J1/44
Filed: 2007-06-11
Granted: 2011-01-17
Abstract: Fotómetro lineal robusto de ganancia
variable. 
     La presente invención se refiere a un nuevo
circuito fotométrico lineal robusto de ganancia variable basado en
compensaciones retroactivas tanto positiva como negativa. Aquí, el
amplificador de transimpedancia utilizado para convertir la
fotocorriente en tensión es compensado con retroacción positiva, con
el objetivo de hacer que el circuito multilazo robustezca la
fotocorriente, compensado las variaciones de corriente que
atraviesan el fotodiodo mientras mantiene a cero la caída de tensión
entre sus terminales. El nuevo dispositivo fotométrico es robusto
frente a variaciones e incertidumbres en los parámetros de los
fotodiodos y frente a variaciones en las condiciones ambientales,
tales como variaciones de temperatura durante el proceso de
medición, disminuyendo considerablemente la desviación de la señal
de salida desde el valor verdadero de medida frente a incertidumbres
paramétricas y a efectos no deseados debidos a la dinámica no
modelada que se manifiestan como ruido de medida.
Patent ES-2525393-B2 (ES)
Title: Nanopartículas de TIO2 dopado con AL o FE con control, cuantitativo de fases anatasa y/o rutilo
Inventor: PECHE HERRERO MARGARITA ANDREA
IPC: C01G23/047
Filed: 2014-09-12
Granted: 2015-06-22
Abstract: Nanopartículas de TiO{sub,2} dopado con Al o Fe con control cuantitativo de fases anatasa y/o rutilo.#Algunas aplicaciones del óxido de titanio en fase anatasa se ven limitadas al transitar ésta a fase rutilo cuando se eleva la temperatura por lo que resulta de interés la existencia de métodos de control de la transición anatasa-rutilo que permitan controlar la mezcla de fases así como que aumenten el rango de temperaturas de trabajo de la anatasa pura en forma de nanopartículas.#En la presente invención se describe la obtención de dióxido de titanio con mezcla controlada de las fases anatasa-rutilo basado en el dopado con Al y Fe sin incorporar otros aditivos. El óxido de titanio así obtenido puede ser aplicado en desarrollos para catálisis, recubrimientos funcionales, materiales para energía, dispositivos optoelectrónicos y sensores de distintos tipos.
Patent AU-2001266726-B2 (AU)
Title: Cold sensitive mutant DNA polymerases
Inventor: KERMEKCHIEV MILKO B
IPC: C12N5/10
Filed: 2001-06-05
Granted: 2006-07-13
Abstract: Provided are mutant DNA polymerases having at least one mutation which exhibit substantially reduced polymerase activity at 25° C. when compared to the same DNA polymerases without the at least one mutation and which exhibit normal or near-normal polymerase activity at optimum temperatures when compared to the same DNA polymerases without the at least one mutation. Also provided are amino acid sequences and nucleic acid sequences encoding such DNA polymerases, and vector plasmids and host cells suitable for the expression of these sequences. Also described herein are improved methods for performing polymerase chain reaction (PCR) amplification and other genetic manipulations and analyses using the mutant DNA polymerases of the invention.
Patent AU-2001269357-B2 (AU)
Title: Method for granting customers access to a product
Inventor: ENGESTROM SVEN
IPC: G06F21/34
Filed: 2001-07-06
Granted: 2005-12-22
Abstract: Example embodiments relate to a method for granting customers access to a product or a set of products. The method may include providing by the customer through a secured communication network, a code to a registration center, wherein the code being unique, transmitting the code from the registration center to an authorization center, retrieving the identifier of the product or the set products from the code, by requesting a data base or calculating the identifier, and transmitting, by the authorization center, an authorization code to the customer terminal, wherein the authorization code allows access to the product or the set of products.
Patent AU-2001296542-B2 (AU)
Title: Triptolide analogs for the treatment of autoimmune and inflammatory disorders
Inventor: VENKATESAN HARIHARAN
IPC: A61P37/00
Filed: 2001-10-02
Granted: 2007-10-25
Abstract: The present invention provides synthetic methods and compositions for treatment of autoimmune and anti-inflammatory disorders comprising administering an effective amount of a derivative of triptolide alone e.g. Formula I or in combination or alternation with other anti-autoimmune or anti-inflammatory compounds.
Patent AU-2002230899-B2 (AU)
Title: Canola event PV-BNGT04(RT73) and compositions and methods for detection thereof
Inventor: ZENG QINGYI
IPC: C12Q1/6895
Filed: 2001-10-22
Granted: 2006-11-09
Abstract: The present invention provides assays for detecting the presence of the PV-BNGT04(RT73) canola event based on the DNA sequence of the recombinant construct inserted into the canola genome and of genomic sequences flanking the insertion site.
Patent AU-2002314609-B2 (AU)
Title: Fixing device for fixing vertebra parts
Inventor: WINDT PAUL DE
IPC: A61B17/58
Filed: 2002-04-24
Granted: 2004-04-22
Abstract: Fixing device for fixing two vertebra parts with respect too one another, and the method for fixing two vertebra parts. The fixing device comprises fixing plates which have to be secured to the relevant vertebra parts. The fixing plates are provided with countersunk openings for receiving the heads of fixing screws. Sleeves which project out of the fixing plates and are to be held in the vertebra adjoin these fixing openings. The fixing plates are fixed with respect to one another with the aid of a connecting system comprising two lips, which lie at a distance from one another, in one fixing plate and a tongue, which can be placed between the said lips, belonging to the other fixing plate. A clamping action of the tongue between the lips can be brought about by a spreading action.
Patent AU-2003210820-B2 (AU)
Title: Light activated gene transduction using ultraviolet light for cell targeted gene delivery
Inventor: RUBERY PAUL T
IPC: C07H21/04
Filed: 2003-01-31
Granted: 2007-12-20
Abstract: This application relates to a method for increasing transduction of a vector into a cell in vitro, said method comprising exposing a cell to UV light having a wavelength of 320 to 400 nm, thereby increasing transduction of an ultraviolet light activated viral vector compared to transduction of the vector in the absence of UV exposure and delivering the ultraviolet light activated viral vector proximate to the cell, wherein the ultraviolet light activated viral vector is selected from the group consisting of an adeno-associated virus vector and a single stranded virus vector.
Patent AU-2003263092-B2 (AU)
Title: Treat retaining pet toy treats therefor
Inventor: MANN CHARLES D
IPC: A01K11/00
Filed: 2003-09-05
Granted: 2009-06-04
Abstract: A non-consumable pet toy ( 100 ) includes a resilient first concave-shaped molded member ( 102 ) having a first peripheral edge ( 130 ) and a resilient second concave-shaped molded member ( 104 ) having a second peripheral edge ( 132 ). The first and second members have a treat-retaining cavity ( 101 ) between them. The treat retaining pet toy also includes a fastener ( 110, 112 ) extending centrally through the treat-retaining cavity. The fastener fastens the first member to the second member such that the first peripheral edge is at a predetermined distance from the second peripheral edge.
Patent AU-2003275152-B2 (AU)
Title: Flush syringe having anti-reflux features
Inventor: HOTTOVY TRACY RAY
IPC: A61F2/958
Filed: 2003-09-23
Granted: 2010-02-18
Abstract: An I.V. flush syringe assembly includes a barrel having an inside surface defining a chamber for retaining fluid, an open proximal end and a distal end with a passageway therethrough in fluid communication with the chamber. An elongate plunger having a proximal end, a distal end and a flexible stopper is slidably positioned in fluid-tight engagement with the inside surface of the barrel for drawing fluid into and out of the chamber by movement of the stopper relative to the barrel. The barrel includes anti-reflux structure for holding said stopper in a partially deflected position after fluid has been delivered from the chamber and the stopper is being force against the distal end of the chamber.
Patent AU-2004224771-B2 (AU)
Title: CAD-system for dental prostheses
Inventor: HERTLEIN GUENTER
IPC: A61C5/77
Filed: 2004-03-26
Granted: 2009-09-03
Abstract: The invention relates to a method based on a CAD system consisting of producing a skeleton (14) satisfying pre-defined stability specifications on the basis of a positive template. For this purpose, the control surfaces, which are calculated on the basis of predetermined coordinates of said positive template, are represented on an output device together with the modified surface shape of an implant.
Patent AU-2004290007-B2 (AU)
Title: Rinse aid composition and method of rinsing a substrate
Inventor: LENTSCH STEVEN E
IPC: C11D1/72
Filed: 2004-11-05
Granted: 2010-03-04
Abstract: A rinse aid composition and methods of making and using the same. A rinse aid composition may generally include an effective amount of a sheeting agent component, and an effective amount of a defoamer component. The sheeting agent component may include one or more alcohol ethoxylate compounds that include an alkyl group that includes 12 or fewer carbon atoms. The defoamer component may include an ethylene oxide containing surfactant configured for reducing the stability of foam that may be created by the one or more alcohol ethoxylate compounds of the sheeting agent in an aqueous solution.
Patent AU-2005201916-B2 (AU)
Title: G protein-coupled receptor up-regulated in prostate cancer and uses thereof
Inventor: AFAR DANIEL E H
IPC: C12N1/21
Filed: 2005-05-05
Granted: 2008-06-19
Abstract: A novel gene (designated PHOR-1) that is highly over-expressed in prostate and other cancers and its encoded protein are described. PHOR-1 is a G protein-coupled receptor with homology to receptors involved in olfaction. PHOR-1 in normal human tissues is restricted to prostate, and this gene is highly over-expressed in prostate cancer as well as in cancers of the kidney, uterus, cervix, stomach and rectum. Consequently, PHOR-1 provides a diagnostic and/or therapeutic target for prostate cancer.
Patent AU-2005256113-B2 (AU)
Title: Anti-glypican 3 antibody
Inventor: YOSHINO TAKESHI
IPC: C07K16/18
Filed: 2005-07-08
Granted: 2011-02-10
Abstract: An antibody capable of binding to a specific region of glypican 3, as well as a humanized antibody created based on that antibody are disclosed. The anti-GPC3 antibody disclosed herein has a higher ADCC activity and CDC activity compared with those of a conventional antibody. The antibody of the present disclosureis useful as a cell growth inhibitor, an anticancer agent and an agent for diagnosis of cancers.
Patent AU-2005291029-B2 (AU)
Title: Modulators of HCV replication
Inventor: IMMACOLATA CONTE
IPC: A61P31/00
Filed: 2005-09-29
Granted: 2011-11-17
Abstract: The present invention is directed to the use of compounds of formula (I): 1 R X 3 R Y ( I) 2 R 5 where X, Y, R1, R2 and R3 are defined therein, which can act as modulators of viral replication and/or virus production, especially of the hepatitis C virus (HCV), in a cell based system.
Patent AU-2006247857-B2 (AU)
Title: Substances, compositions and methods for preventing and treating immune-mediated inflammatory disorders
Inventor: ESCHER ALAN P
IPC: C12N15/00
Filed: 2006-05-05
Granted: 2009-10-22
Abstract: A composition for preventing, delaying the onset of or treating one or more than one immune-mediated inflammatory disorder in an organism who is susceptible to developing the immune-mediated inflammatory disorder, who is developing the immune-mediated inflammatory disorder or who has the immune-mediated inflammatory disorder. A method of preventing, delaying the onset of or treating an organism who is susceptible to developing the immune-mediated inflammatory disorder, who is developing the immune-mediated inflammatory disorder or who has the immune-mediated inflammatory disorder.
Patent AU-2006253624-B2 (AU)
Title: Synthetic resin bottle
Inventor: IIZUKA TAKAO
IPC: B65D1/42
Filed: 2006-05-08
Granted: 2012-08-30
Abstract: A synthetic resin bottle body designed in a shape having increased rigidly and strength in the lateral direction without an increase in wall thickness which results in a rise in material cost. The bottle bodies according to the design can be smoothly used in conveyor lines and vending machines, are not deformed even when they are stored stacked, can exhibit a sufficient pressure-reduction absorbing function for a high-temperature filling application, and are provided at a reduced cost. To achieve the above, a plurality of projected bar-like column parts are formed on a barrel part of the bottle body so as to be tilted at a specified angle relative to the center axis of the bottle body and to be spirally positioned in parallel with each other. Thus, deformation of the bottle body due to pressing force acting on a cylindrical wall of the barrel part from the lateral direction can be suppressed.
Patent AU-2006267051-B2 (AU)
Title: Antisense antibacterial method and compound
Inventor: IVERSEN PATRICK L
IPC: A61K31/70
Filed: 2006-07-13
Granted: 2013-03-07
Abstract: An antibacterial antisense conjugate and method of using the same for treating a bacterial infection in a mammalian host are disclosed. The conjugate includes an antisense oligonucleotide conjugated to a carrier peptide that significantly enhances the antibacterial activity of the oligonucleotide. The antisense oligonucleotide contains 10-20 nucleotide bases and has a targeting nucleic acid sequence complementary to a target sequence containing or within 10 bases, in a downstream direction, of the translational start codon of a bacterial mRNA that encodes a bacterial protein essential for bacterial replication, where the compound binds to a target mRNA with a Tm of between 50° to 600C. The carrier peptide is an arginine-rich peptide containing between 6 and 12 amino acids.